Regenxbio Signs Royalty Deal Worth Up to $250 Million With Healthcare Royalty

In This Article:

Regenxbio (RGNX) said Monday it closed a non-dilutive, limited recourse royalty bond agreement of up

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.